Skip to main content

CMPS COMPASS Pathways plc

Healthcare

12.00

Close 10/9

Open
11.69
High
12.08
Low
11.42
Prev close
11.47
Volume
2.3M
52W 4.88 15.87
Loading candles…

Is COMPASS Pathways plc a buy? Fundamentals and valuation first

As of 2026-10-09

Momentum: Good; Quality: Weak.

Quality Weak ROE, TTM is Lagging.
ROE, TTM (%) -466.49 3th percentile Lagging
Operating margin, TTM (%) — N/A
FCF margin, TTM (%) — N/A
Momentum Good 240-day return is Top; 60-day return is Good.
60-day return (%) -3.46 54th percentile Good
240-day return (%) 91.08 94th percentile Top
Risk / liquidity Neutral 20-day dollar volume is Good, but 60-day annualized volatility is Average.
20-day dollar volume 37,279,052 78th percentile Good
60-day annualized volatility (%) 65.24 67th percentile Average

COMPASS Pathways plc (CMPS) today

1 quant signals active · As of 2026-10-09

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

COMPASS Pathways plc (CMPS) peers and tracking

Watchlist

This page refreshes daily after the close. Add COMPASS Pathways plc to your watchlist to track signal changes on your next visit.

COMPASS Pathways plc (CMPS) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 95.92%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

15 historical occurrences (since 2021-11-01)
Average forward return after Top-quintile 6-month momentum。20-day: Win 33.3%, Sample 15, Median -8%, Excess -9.49%, Beat mkt rate 26.7%；60-day: Win 46.7%, Sample 15, Median -0.3%, Excess -9.75%, Beat mkt rate 40%；120-day: Win 46.7%, Sample 15, Median -13.93%, Excess +1.45%, Beat mkt rate 46.7%

120 days after: historical avg +9.12%

20-day -7.62%
60-day -7.2%
120-day +9.12%
20-day
60-day
120-day
Win
33.3%
46.7%
46.7%
Sample
15
15
15
Median
-8%
-0.3%
-13.93%
Excess
-9.49%
-9.75%
+1.45%
Beat mkt rate
26.7%
40%
46.7%

Over 15 occurrences, 120-day forward avg gained 9.12%, beat the market by 1.45 pts; win rate 46.7%.

More history: Market-wide momentum baseline, Signals not active now

Market-wide momentum baseline

Across 98,394 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.23%, a 57.8% positive-return rate, and +2.88 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

9 times historically; 60-day forward avg -3.21%, win rate 25%, beating the market by -6.1 pts on average.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

Continue researching COMPASS Pathways plc with the evidence above.

Continue in Studio ↗

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.
  • This is an American depositary receipt (ADR). The data does not say how many ordinary shares each ADR represents, so per-share and market-value metrics (P/E, price/book, free-cash-flow yield, EPS growth and earnings surprises) are not computed.
  • ADRs listed on NYSE or NASDAQ are covered as a separate group selected by dollar volume, in addition to the common-stock universe; the 6-month momentum signal ranks each ADR against the liquid US common stocks.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.